124 related articles for article (PubMed ID: 35128935)
21. Prognostic value of
Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891
[TBL] [Abstract][Full Text] [Related]
22.
Ito K; Teng R; Schöder H; Humm JL; Ni A; Michaud L; Nakajima R; Yamashita R; Wolchok JD; Weber WA
J Nucl Med; 2019 Mar; 60(3):335-341. PubMed ID: 30413661
[TBL] [Abstract][Full Text] [Related]
23. Three-Dimensional Image Fusion of
Yu Y; Zhang WB; Liu XJ; Guo CB; Yu GY; Peng X
J Oral Maxillofac Surg; 2017 Jun; 75(6):1301.e1-1301.e15. PubMed ID: 28320612
[TBL] [Abstract][Full Text] [Related]
24. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
25. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
[TBL] [Abstract][Full Text] [Related]
26. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
[TBL] [Abstract][Full Text] [Related]
27. Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma.
Filippi L; Fontana A; Spinelli GP; Rossi L; Bagni O
Nucl Med Commun; 2020 Oct; 41(10):1089-1094. PubMed ID: 32732599
[TBL] [Abstract][Full Text] [Related]
28. Rational use of
Bisschop C; de Heer EC; Brouwers AH; Hospers GAP; Jalving M
Crit Rev Oncol Hematol; 2020 Sep; 153():103044. PubMed ID: 32673997
[No Abstract] [Full Text] [Related]
29. Absolute number of new lesions on
Anwar H; Sachpekidis C; Winkler J; Kopp-Schneider A; Haberkorn U; Hassel JC; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):376-383. PubMed ID: 29124281
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of metabolic response with
Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma.
de Galiza Barbosa F; Riesterer O; Tanadini-Lang S; Stieb S; Studer G; Pruschy M; Huber GF; Huellner MW; Stolzmann P; Veit-Haibach P
Head Neck; 2020 Feb; 42(2):163-170. PubMed ID: 31705729
[TBL] [Abstract][Full Text] [Related]
32. The utility of
Kitajima K; Kawanaka Y; Komoto H; Minami T; Yokoi T; Kuribayashi K; Kijima T; Nakamura A; Hashimoto M; Kondo N; Hasegawa S; Yamakado K
Hell J Nucl Med; 2021; 24(3):186-198. PubMed ID: 34901959
[TBL] [Abstract][Full Text] [Related]
33. 3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT.
Chen H; Li Y; Wu H; Sun L; Lin Q; Zhao L; An H
Strahlenther Onkol; 2015 Feb; 191(2):141-52. PubMed ID: 25163419
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy.
Evangelista L; Cuppari L; Menis J; Bonanno L; Reccia P; Frega S; Pasello G
Nucl Med Commun; 2019 Aug; 40(8):802-807. PubMed ID: 31045745
[TBL] [Abstract][Full Text] [Related]
35. Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic response.
Cabral F; Cruz A; Casaca R; Monteiro C; Ramos P; Pedro C; Brandão F; Fonseca R; Ratão P; Salgado L; Pinto I; Abecasis N
Cancer Radiother; 2020 Dec; 24(8):834-841. PubMed ID: 33191120
[TBL] [Abstract][Full Text] [Related]
36. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
37.
Humbert O; Cadour N; Paquet M; Schiappa R; Poudenx M; Chardin D; Borchiellini D; Benisvy D; Ouvrier MJ; Zwarthoed C; Schiazza A; Ilie M; Ghalloussi H; Koulibaly PM; Darcourt J; Otto J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1158-1167. PubMed ID: 31760467
[TBL] [Abstract][Full Text] [Related]
38. Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?
Dhull VS; Sharma P; Sharma DN; Maharjan S; Suman Kc S; Patel C; Bal C; Kumar R
Int J Gynecol Cancer; 2014 Feb; 24(2):312-20. PubMed ID: 24407578
[TBL] [Abstract][Full Text] [Related]
39. Treatment response evaluation with
Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
[TBL] [Abstract][Full Text] [Related]
40. The value of
Ayati N; Sadeghi R; Kiamanesh Z; Lee ST; Zakavi SR; Scott AM
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):428-448. PubMed ID: 32728798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
